Pulmonx Liabilities And Stockholders Equity from 2010 to 2024

LUNG Stock  USD 6.07  0.19  3.04%   
Pulmonx Corp's Liabilities And Stockholders Equity is increasing over the last several years with slightly volatile swings. Liabilities And Stockholders Equity is predicted to flatten to about 172.3 M. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Pulmonx Corp's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2010-12-31
Previous Quarter
179 M
Current Value
172.3 M
Quarterly Volatility
95.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pulmonx Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulmonx Corp's main balance sheet or income statement drivers, such as Interest Expense of 3.4 M, Selling General Administrative of 93.9 M or Total Revenue of 72.1 M, as well as many indicators such as Price To Sales Ratio of 6.7, Dividend Yield of 0.0 or PTB Ratio of 4.3. Pulmonx financial statements analysis is a perfect complement when working with Pulmonx Corp Valuation or Volatility modules.
  
Check out the analysis of Pulmonx Corp Correlation against competitors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Latest Pulmonx Corp's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Pulmonx Corp over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Pulmonx Corp's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pulmonx Corp's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Pulmonx Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean82,166,749
Geometric Mean39,117,365
Coefficient Of Variation116.24
Mean Deviation84,402,332
Median15,013,000
Standard Deviation95,509,150
Sample Variance9122T
Range248.7M
R-Value0.78
Mean Square Error3801.4T
R-Squared0.61
Significance0.0006
Slope16,721,499
Total Sum of Squares127708T

Pulmonx Liabilities And Stockholders Equity History

2024172.3 M
2023179 M
2022193.7 M
2021235.2 M
2020263.7 M
201953.5 M

About Pulmonx Corp Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Pulmonx Corp income statement, its balance sheet, and the statement of cash flows. Pulmonx Corp investors use historical funamental indicators, such as Pulmonx Corp's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Pulmonx Corp investors may use each financial statement separately, they are all related. The changes in Pulmonx Corp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pulmonx Corp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pulmonx Corp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pulmonx Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity179 M172.3 M

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Pulmonx Stock

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:
Check out the analysis of Pulmonx Corp Correlation against competitors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.54)
Revenue Per Share
1.909
Quarterly Revenue Growth
0.297
Return On Assets
(0.21)
Return On Equity
(0.46)
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.